RS

Renu Sharma

Active Director Director DIN 09647498
DIN 09647498 First appointment Jun 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Renu Sharma

Data last updated:

Renu Sharma is a Director at Shinzo Pharma Private Limited (since 2022). The company operates in Pharma. Shinzo Pharma Private Limited reported revenue of ₹46.4 Lakh (FY 2024).

DIN 09647498
Primary Designation Director
Industry Pharma
First Appointment 22 Jun 2022
Oldest Company Age 4 yrs
Largest company Shinzo Pharma Private Limited · ₹46.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shinzo Pharma Private Limited U24246HP2022PTC009394
Director22 Jun 20222022₹46.4 Lakh (FY 2024)Active

Board colleagues of Renu Sharma

NameDINCompanyDesignation
Vishav Nath Jindal09326445Shinzo Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Shinzo Pharma Private Limited
Premium access

Shareholding and investment profile for Renu Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Sharma

Renu Sharma currently holds 1 directorship: Shinzo Pharma Private Limited (Director, since 22 Jun 2022, revenue ₹46.4 Lakh (FY 2024)).

Renu Sharma was first appointed on 22 Jun 2022 as Director at Shinzo Pharma Private Limited.

The current boards of Renu Sharma's companies include Vishav Nath Jindal (Shinzo Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available